@rachelceller
1 post audited · 6 claims analysed
Science evidence grade
Based on 6 claims across 1 audit
2
Supported
33%
0
Overstated
0%
0
Misleading
0%
4
No Evidence
67%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @rachelceller claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
33%
2 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
67%
4 claims
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(1 post)
“Urgent warning! Please see my review of the patent and productions methods of GLP-1 analogues on my rumble channel. The side effects may cost you your life! Semaglutide, wegovy, Ozempic and so many more ! Cancer laced GLP-1 analogues are made using the following: Human embryonic kidney cells, SV-40 monkey kidney cells, baby hamster kidneys, Human liver cells, genetically modified yeast. Side effects: Blindness, cancer, permanent paralyzation of Gastrointestinal function, depression, death, widespread inflammation and damage to organs like heart, liver, pancreas and gallbladder. https://rumble.com/v7982ew-cancer-laced-glp-1-patent.html”
Claims 1, 4, 5, and 6 (death, blindness, cancer, permanent GI paralysis) lack peer-reviewed or clinical trial support. Claim 2 (semaglutide/Wegovy/Ozempic are GLP-1 analogues) is factually correct and supported by FDA records and clinical evidence. Claim 3 (manufacturing substrates) falls outside published scientific literature and into proprietary regulatory filings. The post's safety allegations are not substantiated by available PubMed or ClinicalTrials.gov data.
Audit another post from @rachelceller
Paste their social post link to add a new audit